Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal recessive nonsyndromic deafness in which the cause of the disease is a mutation in the EPS8 gene.
Features include: Profound hearing impairment.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Ears | 1 | Profound hearing impairment |
EPS8 encodes EGFR pathway substrate 8, signaling adaptor (822 aa). Signaling adapter that controls various cellular protrusions by regulating actin cytoskeleton dynamics and architecture. Highest expression in Artery Tibial (170.1 TPM) and Cells Cultured fibroblasts (161.3 TPM).
Autosomal recessive nonsyndromic hearing loss 102 has been associated with mutations in the EPS8 gene on chromosome 12.
EPS8 is classified as a druggable target (Kinase category) with score 2.5.
Genetic testing for EPS8 is available. Testing is considered supportive for diagnosis.
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 12:32 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center